214 related articles for article (PubMed ID: 35065293)
21. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
22. Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine
Veeravalli S; Karu K; Scott F; Fennema D; Phillips IR; Shephard EA
Drug Metab Dispos; 2018 Jan; 46(1):20-25. PubMed ID: 29070510
[TBL] [Abstract][Full Text] [Related]
23. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.
Qiu L; Tao X; Xiong H; Yu J; Wei H
Food Funct; 2018 Aug; 9(8):4299-4309. PubMed ID: 30039147
[TBL] [Abstract][Full Text] [Related]
24. Molecular and functional characterization of flavin-containing monooxygenases (FMO1-6) in tree shrews.
Uno Y; Makiguchi M; Ushirozako G; Tsukiyama-Kohara K; Shimizu M; Yamazaki H
Comp Biochem Physiol C Toxicol Pharmacol; 2024 Mar; 277():109835. PubMed ID: 38215804
[TBL] [Abstract][Full Text] [Related]
25. Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease.
Ma R; Shi G; Li Y; Shi H
Br J Nutr; 2024 Jun; 131(11):1915-1923. PubMed ID: 38443197
[TBL] [Abstract][Full Text] [Related]
26. Use of Flavin-Containing Monooxygenases for Conversion of Trimethylamine in Salmon Protein Hydrolysates.
Goris M; Puntervoll P; Rojo D; Claussen J; Larsen Ø; Garcia-Moyano A; Almendral D; Barbas C; Ferrer M; Bjerga GEK
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32978141
[TBL] [Abstract][Full Text] [Related]
27. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
28. Dietary Methionine Restriction Alleviates Choline-Induced Tri-Methylamine-N-Oxide (TMAO) Elevation by Manipulating Gut Microbiota in Mice.
Lu M; Yang Y; Xu Y; Wang X; Li B; Le G; Xie Y
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615863
[TBL] [Abstract][Full Text] [Related]
29. Trimethylamine
Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
[TBL] [Abstract][Full Text] [Related]
30. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
[TBL] [Abstract][Full Text] [Related]
31. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
[TBL] [Abstract][Full Text] [Related]
32. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
33. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
[TBL] [Abstract][Full Text] [Related]
34. Cloning, sequencing, and tissue-dependent expression of flavin-containing monooxygenase (FMO) 1 and FMO3 in the dog.
Lattard V; Longin-Sauvageon C; Lachuer J; Delatour P; Benoit E
Drug Metab Dispos; 2002 Feb; 30(2):119-28. PubMed ID: 11792679
[TBL] [Abstract][Full Text] [Related]
35. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
Zeisel SH; Warrier M
Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
[TBL] [Abstract][Full Text] [Related]
36. Unraveling the metabolic pathway of choline-TMA-TMAO: Effects of gypenosides and implications for the therapy of TMAO related diseases.
Zhang Q; Guo X; Xie C; Cao Z; Wang X; Liu L; Yang P
Pharmacol Res; 2021 Nov; 173():105884. PubMed ID: 34530121
[TBL] [Abstract][Full Text] [Related]
37. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
[TBL] [Abstract][Full Text] [Related]
38. FMO1 Promotes Nonalcoholic Fatty Liver Disease Progression by Regulating PPARα Activation and Inducing Ferroptosis.
Zou L; Shi Q; Li Y; Yuan Z; Peng L; Lu J; Zhu H; Ma J
Discov Med; 2023 Aug; 35(177):612-622. PubMed ID: 37553313
[TBL] [Abstract][Full Text] [Related]
39. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.
Simó C; García-Cañas V
Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802
[TBL] [Abstract][Full Text] [Related]
40. Mice, rats, and guinea pigs differ in FMOs expression and tissue concentration of TMAO, a gut bacteria-derived biomarker of cardiovascular and metabolic diseases.
Maksymiuk KM; Szudzik M; Samborowska E; Chabowski D; Konop M; Ufnal M
PLoS One; 2024; 19(1):e0297474. PubMed ID: 38266015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
